SNT 25.7% 4.4¢ syntara limited

Ann: FDA Meeting, Business Review Announcement En, page-5

  1. 2,319 Posts.
    lightbulb Created with Sketch. 347
    re: Ann: FDA Meeting, Business Review Announc... Making sure your trial meets the requirements for the markets you will apply for should have been the first thing they done.

    Bad mistake, and if it wasn't for the fact that the people who f'd up can complete the next trial quicker than bringing in new people, i think (more) heads would have rolled.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.